Growth hormone secretion in Prader-Willi syndrome

Journal of Endocrinological Investigation

Volumn 21, Issue 7, 1998, Pages 418-422

  Grosso, S ^a   Cioni, M ^a   Buoni, S ^a   Peruzzi, L ^a   Pucci, L ^a   Berardi, R ^a,b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

GH deficiency; Growth hormone; Prader Willi syndrome; Short stature

Indexed keywords

GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; OBESITY; PRADER WILLI SYNDROME; SHORT STATURE; THYROID FUNCTION;

EID: 0031725708     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347319     Document Type: Article

References (27)

1. Prader A., Labhart A., Willi H. Ein syndrom von adipositas, kleinwuchs, kryptorchismus und oligophrenia nach myatonieartingem zustand imneugeborenenalter. Schweiz. Med. Wochenschr. 86: 1260, 1956.
2. Stephenson J.B.P. Prader-Willi syndrome: Neonatal presentation and later development. Develop. Med. Child Neurol. 22: 792, 1980.
3. Holm V.A., Cassidy S.B., Butler M.G. Diagnostic criteria for Prader-Willi syndrome. In: Cassidy S.B. (Eds), Prader-Willi syndrome and other chromosome 15q deletion disorders. Springer-Verlag, Heidelberg, NATO ASI Series, 1992, Vol. 61, p. 105.
4. Holm V.A., Cassidy S.B., Butler M.G., Hanchett J.M., Greenswag L.R., Whitman B.Y., Greemberg F. Prader-Willi syndrome: Consensus diagnostic criteria. Pediatrics 97: 398, 1993.
5. Butler M.G. High resolution chromosome analysis and fluorescence in situ hybridization in patients referred for Prader-Willi or Angelman syndrome. Am. J. Med. Genet. 56: 420, 1995.
6. Mascari M.J., Gottlieb W., Rogan P., Butler M.G., Armour J., Jeffreys A., Waller D., Ladda., Nicholls R.D. Frequency of uniparental disomy in Prader-Willi syndrome and implications for molecular diagnosis. New. Engl. J. Med. 326: 1599, 1992.
7. Saitoh S., Suiting K., Cassidy S.B., Conroy J.M., Driscoll D.J., Gabriel J.M., Gillessen-Kaesbach G., Glenn C., Greeswag L.R., Horsthemke B., Kondo I., Kuwajima K., Niikawa N., Rogan P.K., Schwartz S., Seip J., Williams C.A., Nicholls R.D. Clinical spectrum and molecular diagnosis of Angelman and Prader-Willi syndrome patients with an imprinting mutation. Am. J. Med. Genet. 68: 195, 1997.
8. Lee P.D.K., Wilson D.M., Rountree L., Hintz R.L., Rosenfeld R.G. Linear growth response to exogeneous growth hormone in Prader-Willi syndrome. Am. J. Med. Genet. 28: 865, 1987.
9. Costeff H., Holm V.A., Ruvalcaba R., Shaver J. Growth hormone secretion in Prader-Willi syndrome. Acta Paediatr. Scand. 79: 1059, 1990.
10. Cappa M., Grossi A., Borrelli P., Ghigo E., Bellone J., Benedetti S., Carta D., Loche S. Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhart-Willi syndrome. Horm. Res. 39: 51, 1993.
11. Loche S., Pintor C., Cappa M., Puggioni R., Locatelli V., Muller E.E. Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children. Acta Endocrinol. (Copenh.) 120: 624, 1989.
12. Cacciari F., Cicognani A., Piazzoli P., Tassoni P., Zappulla F., Salardi S., Bernardi F. Relationships among the secretion of ACTH, GH and cortisol during the insulin-induced hypoglycemia test in normal and obese child. J. Clin. Endocrinol. Metab. 40: 802, 1975.
13. Galasso C., Sciré G., Boscherini B. Growth hormone and dysmorphic syndromes. Horm. Res. 44 (Suppl 3): 42, 1995.
14. Raiti S., Trias E., Levitsky L., Grossman M.S. Oxandrolone and human growth hormone. Am. J. Dis. Child. 126: 597, 1973.
15. Chiumello G., Manzoni P., Beccaria L., Simone P. Secondary obesity. Nutrition. Res. 13 (Suppl. 1): S109, 1993.
16. Ruvalcaba R.H.A., Holm V.A. Effects of growth hormone in Prader-Willi syndrome. A case report. Clin. Pediatr. 5: 292, 1993.
17. Nilsson K.O. What is the value of growth hormone treatment in short children with specified syndrome? Turner's syndrome, osteochondrodysplasias, Prader-Willi syndrome, Noonan syndrome. Acta Paediatr. Scand. 362 (Suppl): 61, 1989.
18. Angulo M., Castro-Magana M., Mazur B., Canas J.A., Vitollo P.M., Sarrantonio M. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. J. Pediatr. Endocr. Metab. 9: 393, 1996.
19. Kamel A., Margery V., Norstedt G., Thoren M., Lindgren A.C., Bronnegard M., Marcus C. Growth hormone (GH) treatment up-regulates GH receptor mRNA levels in adipocytes from patients with GH deficiency and Prader-Willi syndrome. Pediatr. Res. 30: 418, 1995.
20. Greenswag L.R. Adults with Prader-Willi sindrome: A survey of 232 cases. Dev. Med. Child Neurol. 29: 145, 1987.
21. Calisti L., Giannessi N., Cesaretti G., Saggese G. Studio endocrino nella sindrome di Prader-Willi. A proposito di 5 casi. Minerva Pediatr. 43: 587, 1991.
22. Fesseler W.H., Bierich J.R. Prader-Labhart-Willi syndrome. Monatsschr Kinderheilkd 131: 844, 1983.
23. Bray G.A., Dahms W.T., Swerdloff R.S., Fiser R.H., Atkinson R.L, Carrel R.E. The Prader-Willi syndrome: A study of 40 patients and a review of the literature. Medicine 62: 59, 1983.
24. Hasen J., Wu R.H. Growth hormone secretion in the Prader-Willi syndrome. Fert. Steril. 38: 499, 1982.
25. Michel G., Chaussain J.L, Job J.C. Les explorations endocriniennes dans la syndrome de Prader, Labhart et Willi. Arch. Franc. Pediatr. 33: 467, 1976.
26. Tolis G., Lewis W., Verdy M., Friesen H.G., Solomon S., Pagalis G., Pavlatos F., Fessas P.H., Rochefort J.G. Anterior pituitary function in the Prader-Labhart-Willi (PLW) syndrome. J. Clin. Endocrinol. Metab 39: 1061, 1974.
27. Parra A., Cervantes C., Shultz R.B. Immunoreactive insulin and growth hormone responses in patients with Prader-Willi syndrome. J. Pediatr. 83: 587, 1973.